Loading Now

Summary of New Methods For Drug Synergy Prediction: a Mini-review, by Fatemeh Abbasi and Juho Rousu


New methods for drug synergy prediction: a mini-review

by Fatemeh Abbasi, Juho Rousu

First submitted to arxiv on: 3 Apr 2024

Categories

  • Main: Machine Learning (cs.LG)
  • Secondary: Artificial Intelligence (cs.AI); Quantitative Methods (q-bio.QM)

     Abstract of paper      PDF of paper


GrooveSquid.com Paper Summaries

GrooveSquid.com’s goal is to make artificial intelligence research accessible by summarizing AI papers in simpler terms. Each summary below covers the same AI paper, written at different levels of difficulty. The medium difficulty and low difficulty versions are original summaries written by GrooveSquid.com, while the high difficulty version is the paper’s original abstract. Feel free to learn from the version that suits you best!

Summary difficulty Written by Summary
High Paper authors High Difficulty Summary
Read the original abstract here
Medium GrooveSquid.com (original content) Medium Difficulty Summary
This mini-review explores the rapidly advancing field of predicting drug combination synergy through high-throughput combinatorial screens. Since 2021, over thirty original machine learning methods have been published, with a majority relying on deep learning techniques. The review aims to unify these papers by highlighting core technologies, data sources, input data types, and evaluation protocols. Key findings include the accurate prediction of synergy scenarios involving known drugs or cell lines, while those involving new drugs or cell lines still struggle to achieve accuracy.
Low GrooveSquid.com (original content) Low Difficulty Summary
The paper reviews new methods for predicting drug combination synergy. It looks at how machine learning is being used in this area. Over 30 papers have been published since 2021, with most using deep learning. The review shows that the best methods work well when predicting combinations of known drugs or cell lines. However, predicting new drug combinations still has some challenges.

Keywords

» Artificial intelligence  » Deep learning  » Machine learning